Intellipharmaceutics International Inc.

(IPCI) Trade

Symbol has changed to a new ticker symbol

(IPCI:CA)

By |

Profile

IntelliPharmaCeutics International Inc is a pharmaceutical company. The Company is engaged in the research, development, and manufacturing of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix technology is a multidimensional controlled release drug delivery platform that can be applied to the development of a range of existing and new pharmaceuticals. Its ongoing drug development programs are at various stages of development in therapeutic areas that include neurology, cardiovascular, GIT, pain. The company's lead product, a generic of Focalin XR, is partnered with Par Pharmaceutical, Inc. and received FDA approval.

Contact Information

Website: www.intellipharmaceutics.com
Email: investors@intellipharmaceutics.com
Main Phone: +1 416 798-3001
Address: 30 Worcester Road
Address 2: Suite 1800
State: ON
City / Town: Toronto
Country: CAN
Postal Code: M9W 5X2

Issuer Information

Exchange: NSC
CEO: Isa Odidi
Employees: 59
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Profile

IntelliPharmaCeutics International Inc is a pharmaceutical company. The Company is engaged in the research, development, and manufacturing of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix technology is a multidimensional controlled release drug delivery platform that can be applied to the development of a range of existing and new pharmaceuticals. Its ongoing drug development programs are at various stages of development in therapeutic areas that include neurology, cardiovascular, GIT, pain. The company's lead product, a generic of Focalin XR, is partnered with Par Pharmaceutical, Inc. and received FDA approval.

Contact Information

Website: www.intellipharmaceutics.com
Email: investors@intellipharmaceutics.com
Main Phone: +1 416 798-3001
Address: 30 Worcester Road
Address 2: Suite 1800
State: ON
City / Town: Toronto
Country: CAN
Postal Code: M9W 5X2

Issuer Information

Exchange: NSC
CEO: Isa Odidi
Employees: 59
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 3 3 3 3
Low Target Price Estimate 2.5 2.5 2.5 2.5
Mean Target Price Estimate 2.75 2.75 2.75 2.75
Standard Deviation 0.35 0.35 0.35 0.35
Date of Most Recent Estimate 05/29/18 02/26/18 02/26/18 05/29/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.67 1.67 1.67 1.67